Filing Details
- Accession Number:
- 0001593968-19-002347
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-12-18 21:50:43
- Reporting Period:
- 2019-12-17
- Accepted Time:
- 2019-12-18 21:50:43
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1397702 | Silk Road Medical Inc | SILK | Surgical & Medical Instruments & Apparatus (3841) | 208777622 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1770296 | Richard Ruedy | C/O Silk Road Medical, Inc. 1213 Innsbruck Drive Sunnyvale CA 94089 | Evpclin&Amp;Reg.affairs&Amp;Qa | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-12-18 | 32,222 | $0.68 | 32,609 | No | 4 | M | Direct | |
Common Stock | Disposition | 2019-12-18 | 32,222 | $38.00 | 387 | No | 4 | S | Direct | |
Common Stock | Disposition | 2019-12-17 | 10,000 | $36.09 | 10,070 | No | 4 | S | Indirect | By Spouse |
Common Stock | Disposition | 2019-12-18 | 10,000 | $35.55 | 70 | No | 4 | S | Indirect | By Spouse |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Indirect | By Spouse |
No | 4 | S | Indirect | By Spouse |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Option (right to buy) | Disposition | 2019-12-18 | 32,222 | $0.00 | 32,222 | $0.68 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2011-10-11 | 2020-11-15 | No | 4 | M | Direct |
Footnotes
- The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 13, 2019.
- All of the shares subject to this option are fully vested and exercisable as of the date hereof.